By Global Consultants Review Team ,
FMG Leading has expanded its healthcare advisory capabilities with the addition of Doug Van Wie as Managing Director.
The appointment brings extensive experience in healthcare strategy, M&A, commercial due diligence, growth strategy and post-transaction transformation to the firm.
FMG Leading works with healthcare executives, investors and entrepreneurs, particularly within investor-backed healthcare organizations.
The firm focuses on connecting strategy, leadership and execution to help clients improve performance across the investment lifecycle.
Doug Van Wie, Managing Director at FMG Leading, brings a background that spans healthcare consulting, transactions, business strategy and transformation.
His experience includes M&A and post-transaction advisory, commercial and vendor due diligence, enterprise growth strategy, value creation planning and transformation governance. His background is particularly relevant to healthcare investors and executives looking to identify opportunities while reducing strategic and operational risks.
Van Wie has supported more than 100 transactions during his career, including major healthcare deals involving specialty practices and healthcare technology. His experience covers healthcare providers, payers, pharmacy businesses and healthcare technology companies.
The addition gives FMG Leading another senior advisor with experience across multiple stages of the healthcare investment lifecycle.
“Today’s healthcare leaders require a combination of deep insight and expert advice to help them build organizations that genuinely make healthcare work, better.” - Doug Van Wie, Managing Director at FMG Leading
His appointment reflects the increasing demand for specialized healthcare strategy expertise as organizations deal with changing reimbursement models, technology developments and evolving approaches to healthcare delivery.
For healthcare investors, these changes can affect everything from investment decisions and market positioning to growth plans and post-acquisition performance.
Healthcare companies are operating in an environment where strategic decisions can have a significant impact on both financial performance and patient outcomes.
Technology is changing how healthcare services are delivered, while new business models and reimbursement pressures are influencing the way organizations plan for growth. At the same time, healthcare investors are placing greater emphasis on value creation throughout the investment lifecycle.
FMG Leading's model is designed around this connection between strategy and execution. The firm describes its approach as bringing together market intelligence, strategy development and testing, leadership alignment and activation for healthcare executives and investors.
Van Wie's experience complements this approach by bringing transaction and healthcare strategy expertise into the firm's advisory platform.
One of the important aspects of Van Wie's background is his experience both before and after healthcare transactions.
Commercial and vendor due diligence can help investors understand the attractiveness and risks of a potential investment before a deal closes. Following an acquisition, organizations may need to develop growth strategies, align leadership teams and establish transformation programs.
Van Wie has worked across these areas, giving him experience with the challenges that can emerge throughout an investment.
His background includes supporting healthcare transactions and advising organizations on growth strategy, value creation and transformation governance. This combination is particularly relevant for private equity-backed healthcare companies where investors and management teams need to translate an investment thesis into measurable business performance.
Before joining FMG Leading, Van Wie co-founded L.E.K. Consulting's Atlanta office and established its pharmacy practice.
His consulting career included work with major pharmacy businesses and other healthcare organizations. He also gained operating experience through commercial and product roles at healthcare technology company Influence Health.
That combination of consulting and operating experience gives Van Wie exposure to both strategic decision-making and implementation.
For healthcare consulting firms, professionals with experience on both sides of the advisory relationship can bring a practical perspective to client engagements. Rather than focusing only on recommendations, they can help organizations consider how strategies can be implemented within real operating environments.
Van Wie's appointment follows FMG Leading's acquisition of BroadBranch Advisors, a market intelligence and strategic advisory firm. FMG Leading announced the acquisition in August 2026, with the transaction having taken effect on July 31, 2026. Terms of the deal were not disclosed.
The acquisition added market intelligence capabilities to FMG Leading's platform, including competitive and customer data that can support strategic decision-making.
FMG Leading said the combination of market intelligence, organizational health data and outside-in competitive context is intended to help healthcare executives and investors make more informed decisions and move insights into action.
Van Wie's appointment therefore comes as the firm is broadening its advisory capabilities.
For private equity investors and healthcare executives, strategy does not stop once a transaction is completed.
Organizations may need to determine how to accelerate growth, improve operational performance, strengthen leadership teams and prepare for future stages of the investment lifecycle.
FMG Leading focuses specifically on helping healthcare CEOs and investors address these challenges. Its current platform covers activities ranging from diligence and onboarding to value creation and exit preparation.
Van Wie's experience across transactions and healthcare strategy can support this broader approach.
His knowledge of M&A also gives him insight into the questions investors need to answer before committing capital, while his experience in post-transaction advisory provides a perspective on what organizations need after a deal closes.
The appointment of Doug Van Wie, Managing Director at FMG Leading, highlights the growing importance of specialized expertise within healthcare consulting.
As healthcare organizations face technological change, evolving care-delivery models and continued investment activity, executives and investors increasingly require advisors who understand both the industry and the investment environment.
Van Wie's experience across healthcare strategy, M&A, due diligence, growth planning and transformation adds depth to FMG Leading's existing advisory capabilities.
The firm, founded in 1984, says it has more than four decades of experience advising healthcare leaders and has worked with hundreds of CEOs and management teams through critical points in their organizations' growth.
With Van Wie joining the leadership team, FMG Leading is further strengthening its ability to advise healthcare organizations from investment entry through growth, transformation and eventual exit.
The move ultimately reinforces the firm's focus on helping healthcare investors and executives connect strategy, leadership and execution to create sustainable business performance.
We use cookies to ensure you get the best experience on our website. Read more...
